 Connection
Jelena Klawitter to Apoptosis
This is a "connection" page, showing publications Jelena Klawitter has written about Apoptosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.067 |
|
|
|
-
Klawitter J, Kominsky DJ, Brown JL, Klawitter J, Christians U, Leibfritz D, Melo JV, Eckhardt SG, Serkova NJ. Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells. Br J Pharmacol. 2009 Sep; 158(2):588-600.
Score: 0.041
-
Niederlechner S, Klawitter J, Baird C, Kallweit AR, Christians U, Wischmeyer PE. Fibronectin-integrin signaling is required for L-glutamine's protection against gut injury. PLoS One. 2012; 7(11):e50185.
Score: 0.013
-
Tanabe K, Lanaspa MA, Kitagawa W, Rivard CJ, Miyazaki M, Klawitter J, Schreiner GF, Saleem MA, Mathieson PW, Makino H, Johnson RJ, Nakagawa T. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse. Am J Physiol Renal Physiol. 2012 May 01; 302(9):F1151-60.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|